- 9 January, 2025
Should I buy Kellogg Company shares after Argus raised its price target to $72?
Kellogg Company (NYSE: K) is a stable company with a good position in the market, but the stock price is still not able to stabilize
Should you buy Beyond Meat stock after Bernstein’s recommendation?
Shares plant-based food company Beyond Meat Inc. (NASDAQ:BYND) on Monday gained 10% after Bernstein analyst Alexis Howard gave a buy recommendation. The analyst cited multi-state
Media expert says Amazon has no interest in competing directly with Disney
The Wall Street Journal reported that Amazon Inc. (NASDAQ: AMZN) inched closer to acquiring MGM Studios for about $9 billion (£6.37 billion) on Tuesday. In
Amazon inches closer to finalizing MGM’s library
Amazon.com Inc. (NASDAQ: AMZN) is poised to announce a deal to acquire the famed MGM Studios Inc. for almost $9 billion, including debt, according to
Netflix stock price outlook as Amazon buys MGM
The Netflix (NASDAQ: NFLX) stock price is up by more than 0.60% in premarket trading even as competition in the streaming space increases. The stock
3 key takeaways from Nordson Corp’s Q2 earnings report
Nordson Corp. (NASDAQ: NDSN) reported its financial results for the fiscal second quarter on Monday that beat Wall Street estimates on the back of robust
Peloton will open its first-ever US manufacturing plant
Peloton Interactive Inc. (NASDAQ: PTON) plans on building a manufacturing plant in Ohio, said the home fitness equipment maker on Monday. Its first-ever U.S. factory
Apple will ‘lose the war’ against Epic
Apple Inc (NASDAQ: AAPL) has been embroiled in a legal battle with Epic Games Inc. since last August when Epic sued Apple for violating antitrust
Should you buy Nvidia stock after announcing a 4-for-1 split?
Shares of Nvidia Corp (NASDAQ:NVDA) popped more than 10% late last week following the announcement of a 4-for-1 stock split. The company said on Friday
Here’s why Scopus BioPharma gained 200% on Monday
Scopus BioPharma Inc. (NASDAQ: SCPS) said the U.S. Food and Drug Administration FDA approved its IND (investigational new drug) application on Monday for CpG-STAT3siRNA –